Merlin Capital »

Intellia Therapeutics shares owned by Merlin Capital

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Merlin Capital from 13F filings

Historical chart of Merlin Capital investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Merlin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Merlin Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $818k 27k 30.49
2023-09-30 $586k 19k 31.62
2023-06-30 $719k 18k 40.78
2023-03-31 $470k 13k 37.27
2022-12-31 $429k 12k 34.89
2022-09-30 $652k 12k 55.93
2022-06-30 $630k 12k 51.75
2022-03-31 $841k 12k 72.66
2021-12-31 $775k 6.6k 118.23